Rise, and pronounced regional variation, in methylphenidate, amphetamine, and lisdexamfetamine distribution in the United States

Background The prescription stimulants methylphenidate, amphetamine, and lisdexamfetamine are sympathomimetic drugs with therapeutic use. They are designated in the United States as Schedule II substances, defined by the 1970 Controlled Substances Act as having a “high potential for abuse”. Changing...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sneha M. Vaddadi, Nicholas J. Czelatka, Belsy D. Gutierrez, Bhumika C. Maddineni, Kenneth L. McCall, Brian J. Piper
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	PeerJ Inc. 2021-12-01
Saila:	PeerJ
Gaiak:	Amphetamine Methylphenidate Lisdexamfetamine Attention Deficit Hyperactivity Disorder Pharmacoepidemiology
Sarrera elektronikoa:	https://peerj.com/articles/12619.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!